Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 77
Central Nervous System Drugs 60
Endocrine and Metabolic Disorders Drugs 46
Drug Discovery 32
Infusions and Injectables 25
Musculoskeletal Disorders Drugs 24
Surgical Procedures 20
Pharmaceuticals 17
Biopharmaceuticals 15
Prostate Cancer Drugs 12
Clinical Trials 12
Drug Delivery 11
Liver Cancer Drugs 10
Women's Health 10
Neurology 9
Dermatology 9
Pancreatic Cancer Drugs 9
Lung Cancer Drugs 8
Biotechnology 7
Healthcare Services 7
Immune Disorders Drugs 7
Medical Devices 7
Breast Cancer Drugs 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Thyroid Cancer Drugs 6
Company Reports 5
Ovarian Cancer Drugs 5
Oncology 5
Dermatological Drugs 5
Sexual and Reproductive Health Drugs 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Bladder Cancer Drugs 4
Genomics 4
Enzymes 4
Over the Counter (OTC) Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Managed Care 3
Kidney Cancer Drugs 3
Pediatrics 3
Gastroenterology 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Healthcare 2
Diabetes Devices 2
Needles and Syringes 2
Surgical Devices 2
Biosimilars and Biosuperiors 2
Skin Cancer Drugs 2
Nanomedicine 2
Urological Disorders Drugs 2
Pharmaceutical Manufacturing 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Transdermal and Transmucosal Drug Delivery 1
Biomaterials 1
Hematology 1
Hematological Drugs 1
Nuclear Medicine and Radiopharmacology 1
Other Healthcare Facilities 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

419 Results (Page 14 of 21)
- Relevance
  Sort by

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

 Report
March 2019
220 Pages
Global

From

€2962EUR$2,999USD£2,469GBP

Human Growth Hormone (HGH) Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

 Report
March 2021
120 Pages
Global

From

€4692EUR$4,750USD£3,910GBP

HPV Associated Disorders Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Nanomedicine Market by Molecule Type, Modality, Application, Indication - Global Forecast 2025-2030

 Report
October 2024
198 Pages
Global

From

€3502EUR$3,545USD£2,918GBP

€3891EUR$3,939USD£3,243GBP

Pancreatic Cancer Treatment Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€4099EUR$4,150USD£3,416GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Bladder Cancer Drugs Global Market Report 2024

 Report
November 2023
175 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Market Spotlight: Neuroendocrine tumors (NET)

 Report
May 2021
42 Pages
Global

€1302EUR$1,318USD£1,085GBP

Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
109 Pages
Global

From

€1975EUR$2,000USD£1,646GBP

Liposome Development and Liposome Manufacturing Services Market, 2022-2035: Distribution by Type of Product Formulation, Scale of Operation, End User Industry, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
December 2022
226 Pages
Global

From

€4740EUR$4,799USD£3,951GBP

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
224 Pages
Global

From

€4805EUR$4,865USD£4,005GBP

€6865EUR$6,950USD£5,721GBP

Royalty Rates in Pharmaceutical and Biotechnology Deals

 Report
August 2024
500 Pages
Global

From

€3946EUR$3,995USD£3,289GBP

Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
292 Pages
Global

From

€2469EUR$2,500USD£2,058GBP

Unresectable Hepatocellular Carcinoma Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Locally Advanced Pancreatic Cancer Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

 Report
October 2023
190 Pages
Global

From

€4445EUR$4,500USD£3,704GBP

Contract Injectable Packaging Trends in the Bio/Pharma Industry

 Report
August 2022
96 Pages
Global

From

€4934EUR$4,995USD£4,112GBP

Colorectal Cancer Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Pancreatic Cancer Drugs Global Market Opportunities and Strategies to 2032

 Report
April 2023
295 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
140 Pages
Global

From

€4740EUR$4,799USD£3,951GBP

HER2 Inhibitors Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4939EUR$5,000USD£4,116GBP

Pancreatic Cancer - Competitive landscape, 2023

 Report
April 2023
450 Pages
Global

From

€2247EUR$2,275USD£1,873GBP

€3210EUR$3,250USD£2,675GBP

419 Results (Page 14 of 21)
- 1
- 12
- 13
- 14
- 15
- 16

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.